We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

46 hedge funds and large institutions have $844M invested in Tango Therapeutics in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

464% more capital invested

Capital invested by funds: $150M → $844M (+$695M)

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

125% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 12

48% more funds holding

Funds holding: 31 → 46 (+15)

13.31% more ownership

Funds ownership: 61.53% → 74.84% (+13%)

Holders
46
Holders Change
+15
Holders Change %
+48.39%
% of All Funds
0.81%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
27
Increased
10
Reduced
4
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TGI
TRV GP IV
Massachusetts
+$232M
2
BC
Boxer Capital
California
+$82.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$74.9M
4
CC
Casdin Capital
New York
+$65.8M
5
HA
HHLR Advisors
Cayman Islands
+$52.4M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.69M
2
PA
Perceptive Advisors
New York
-$5.69M
3
FCMV
Foresite Capital Management V
California
-$4.55M
4
DCM
Driehaus Capital Management
Illinois
-$3.82M
5
LGM
Logos Global Management
California
-$2.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$1.46M +$1.36M +113,150 New
NCM
27
Nantahala Capital Management
Connecticut
$1.29M +$1.2M +100,000 New
PVI
28
Pura Vida Investments
New York
$1.1M -$170K -14,159 -14%
Ensign Peak Advisors
29
Ensign Peak Advisors
Utah
$692K +$641K +53,500 New
AAA
30
Affinity Asset Advisors
New York
$647K -$599K -50,000 -50%
Janney Montgomery Scott
31
Janney Montgomery Scott
Pennsylvania
$517K +$479K +40,000 New
AH
32
Aviva Holdings
Bahamas
$349K +$323K +26,961 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$326K +$302K +25,221 New
Charles Schwab
34
Charles Schwab
California
$315K +$291K +24,311 New
CSS
35
Cubist Systematic Strategies
Connecticut
$204K +$189K +15,792 New
Walleye Trading
36
Walleye Trading
New York
$178K +$165K +13,805 New
OWP
37
Old Well Partners
North Carolina
$149K – – –
Victory Capital Management
38
Victory Capital Management
Texas
$143K +$132K +11,022 New
PCM
39
Penserra Capital Management
California
$133K +$124K +10,344 New
Citigroup
40
Citigroup
New York
$41K +$38K +3,169 New
Morgan Stanley
41
Morgan Stanley
New York
$24K +$22.1K +1,847 New
JP Morgan Chase
42
JP Morgan Chase
New York
$23K +$21.7K +1,812 New
TRCT
43
Tower Research Capital (TRC)
New York
$11K +$9.93K +828 New
Wells Fargo
44
Wells Fargo
California
$5K +$4.69K +391 New
Walleye Capital
45
Walleye Capital
New York
$535 +$496K +41,415 New
Adage Capital Partners
46
Adage Capital Partners
Massachusetts
– -$5.69M -500,000 Closed
PA
47
Perceptive Advisors
New York
– -$5.69M -500,000 Closed
FCMV
48
Foresite Capital Management V
California
– -$4.55M -400,000 Closed
DCM
49
Driehaus Capital Management
Illinois
– -$3.82M -336,100 Closed
LGM
50
Logos Global Management
California
– -$2.28M -200,000 Closed
1
2
3

TNGX Hedge Fund Activity: Q3 2021 in Review

46 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q3 2021, worth a combined $844M — up 464% from $150M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TNGX positions and 12 closed out — a net gain of 15 holders — while 10 added to existing stakes and 4 trimmed.

The largest buyer was TRV GP IV, opening a new position worth an estimated $232M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $5.69M sold.

  • 46 institutional investors held Tango Therapeutics (TNGX) as of Q3 2021, up from 31 in Q2 2021.
  • Funds reported $844M of Tango Therapeutics stock for Q3 2021, up 464% quarter-over-quarter.
  • 27 funds opened new Tango Therapeutics positions in Q3 2021 and 12 closed out, a net change of +15 holders.
  • The largest Tango Therapeutics buyer in Q3 2021 was TRV GP IV, an estimated $232M added.
  • The largest Tango Therapeutics seller in Q3 2021 was Adage Capital Partners, an estimated $5.69M sold.

Based on aggregated 13F filings for Q3 2021.